niacinamide has been researched along with Hyperparathyroidism, Secondary in 4 studies
nicotinamide : A pyridinecarboxamide that is pyridine in which the hydrogen at position 3 is replaced by a carboxamide group.
Hyperparathyroidism, Secondary: Abnormally elevated PARATHYROID HORMONE secretion as a response to HYPOCALCEMIA. It is caused by chronic KIDNEY FAILURE or other abnormalities in the controls of bone and mineral metabolism, leading to various BONE DISEASES, such as RENAL OSTEODYSTROPHY.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Secondary hyperparathyroidism has a significant impact on morbidity and mortality due to skeletal and extraskeletal manifestations." | 6.44 | Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan. ( Iseki, K, 2008) |
| "Secondary hyperparathyroidism has a significant impact on morbidity and mortality due to skeletal and extraskeletal manifestations." | 2.44 | Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan. ( Iseki, K, 2008) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Takahashi, Y | 1 |
| Tanaka, A | 1 |
| Nakamura, T | 1 |
| Fukuwatari, T | 1 |
| Shibata, K | 1 |
| Shimada, N | 1 |
| Ebihara, I | 1 |
| Koide, H | 1 |
| Bover, J | 1 |
| Ortiz-Herbener, F | 1 |
| Ballarín, J | 1 |
| Andrés, E | 1 |
| Barceló, P | 1 |
| Rieu, P | 1 |
| Iseki, K | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Comparison of Nicotinamide and Sevelamer Hydrochloride on Phosphatemia Control on Chronic Hemodialysed Patients[NCT01011699] | Phase 3 | 176 participants (Actual) | Interventional | 2010-01-31 | Terminated (stopped due to Financial problem) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 reviews available for niacinamide and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
[New therapy strategies in secondary hyperparathyroidism on dialysis (I): new concepts, new treatments].
Topics: Algorithms; Bile Acids and Salts; Calcium; Cardiovascular Diseases; Disease Progression; Drug Therap | 2005 |
Pharmacological control of secondary hyperparathyroidism in chronic hemodialysis patients: cinacalcet is coming to Japan.
Topics: Calcinosis; Calcium; Chelating Agents; Cinacalcet; Coronary Artery Disease; Ethanol; Humans; Hyperpa | 2008 |
1 trial available for niacinamide and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
Nicotinamide suppresses hyperphosphatemia in hemodialysis patients.
Topics: Aged; Calcium; Female; Humans; Hyperparathyroidism, Secondary; Kidney Failure, Chronic; Male; Middle | 2004 |
1 other study available for niacinamide and Hyperparathyroidism, Secondary
| Article | Year |
|---|---|
[Treatment of hyperphosphatemia in hemodialysis patients].
Topics: Calcium; Diet; Humans; Hyperparathyroidism, Secondary; Niacinamide; Parathyroidectomy; Phosphates; R | 2005 |